This inventor holds 20 USPTO granted patents, primarily in Neutrophil Inhibitors. Top assignees: Corvas International, Inc., Dendreon Corporation. Active years: 1998-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Boulder, CA (US) (2000)
- Thousand Oaks, CA (US) (2004)
- Escondido, CA (US) (1998 - 2005)
- Boulder, CO (US) (2000 - 2005)
Company Filing History:
Years Active: 1998-2005
Areas of Expertise:
Title: Matthew Moyle: Innovator in Immunotherapy
Introduction
Matthew Moyle, based in Escondido, California, is an accomplished inventor with a remarkable portfolio of 20 patents. His work primarily focuses on innovations in immunotherapy, particularly in the form of compositions that target neutrophil activity. Moyle's inventions have contributed significantly to the field of medicine, aiming to improve therapeutic approaches to inflammatory conditions.
Latest Patents
Among his latest patents, Moyle has developed compositions enriched for Neutrophil Inhibitory Factor. These compositions are designed to inhibit neutrophil activity, including their adhesion to vascular endothelial cells. Moreover, he has created recombinant Neutrophil Inhibitory Factors that also serve this purpose. Such innovations are crucial for therapies addressing abnormal or undesired inflammatory responses. Additionally, he holds patents on nematode-extracted serine protease inhibitors and anticoagulant proteins. These proteins, characterized by having at least one NAP domain, can exhibit factor Xa inhibitory activity and inhibit factor VIIa/TF. They can be isolated from natural sources like nematodes or produced through chemical synthesis or recombinant DNA techniques.
Career Highlights
Moyle has built his career by working with reputable companies in the biotechnology sector. Notably, he has contributed to Corvas International, Inc. and Dendreon Corporation. His work in these organizations has been instrumental in advancing research and development in therapeutic interventions.
Collaborations
Throughout his career, Moyle has collaborated with esteemed professionals in the field, including George Phillip Vlasuk and Yves Rene LaRoche. These partnerships have fostered significant advancements in the research and development of innovative therapeutic methods.
Conclusion
Matthew Moyle stands out as a prolific inventor in the medical field, with numerous patents that highlight his innovative contributions to immunotherapy. His strategic collaborations and work with leading companies continue to influence the landscape of therapeutic science, paving the way for advancements that address critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile